<?xml version="1.0" encoding="UTF-8"?>
<p id="Par5">The main goal of this analysis is the evaluation of ASCT's toxicity in elderly patients (&gt; 65 years old) when compared to a younger cohort (≤ 65 years old). Secondary endpoints included the efficacy of ASCT and evaluation of OS and progression-free survival (PFS) in the transplanted.</p>
